SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DUSA (DUSA) Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron Harvey who wrote (50)1/11/1999 11:42:00 AM
From: ouija  Read Replies (1) of 101
 
My expectations are higher. In general I would agree with you. In this case, timing works to DUSA favor I think. They already put out one release of new news, and any additional new news released at the conference, which I assume will happen since they wouldn't have dropped all new news prior to the conference, should produce buying on the news rather than selling on the news. And, they is a lot of potential news with other trial results, partnering, FDA progress on AK, upcoming panel, etc. There is bound to be new news at the conference which should trigger a realtime reaction. The fuse is getting too short here for pm's to have time to go back to the investment committee and expect to get the same price as at the conference.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News